Cargando…

Wild-Type Transthyretin Amyloidosis in Female Patients　― Consideration of Sex Differences ―

Background: With recent advances in non-invasive diagnostic tools, some studies indicate that wild-type transthyretin amyloidosis (ATTRwt) may be more common in females than previously reported. However, the clinical characteristics of female ATTRwt patients have not been determined. Methods and Res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochi, Yuri, Kubo, Toru, Baba, Yuichi, Sugiura, Kenta, Ueda, Motoko, Miyagawa, Kazuya, Noguchi, Tatsuya, Hirota, Takayoshi, Hamada, Tomoyuki, Yamasaki, Naohito, Kitaoka, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2021
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338431/ https://www.ncbi.nlm.nih.gov/pubmed/34414336 http://dx.doi.org/10.1253/circrep.CR-21-0067

Ejemplares similares

Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
por: Ochi, Yuri, et al.
Publicado: (2020)

Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release
por: Sugiura, Kenta, et al.
Publicado: (2021)

Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
por: Okamoto, Nao, et al.
Publicado: (2019)

Very long‐term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years
por: Sugiura, Kenta, et al.
Publicado: (2022)

A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy
por: Ochi, Yuri, et al.
Publicado: (2021)

Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
por: Sugiura, Kenta, et al.
Publicado: (2020)

Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis　― Reply ―
por: Ochi, Yuri, et al.
Publicado: (2021)

A single atrial septal defect masquerading as multiple defects due to a refraction artifact – A cautionary note
por: Ochi, Yuri, et al.
Publicado: (2020)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2020)

A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries
por: Sugiura, Kenta, et al.
Publicado: (2022)

High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement
por: Baba, Yuichi, et al.
Publicado: (2023)

Where Is the Left Atrial Appendage Wall? Caution during Transesophageal Echocardiography
por: Baba, Yuichi, et al.
Publicado: (2023)

Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
por: Kubo, Toru, et al.
Publicado: (2015)

Ruptured Thoracic Aortic Aneurysm Imaging Pulmonary Embolism
por: Baba, Yuichi, et al.
Publicado: (2018)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Transient decrease in the depth of the negative T wave in apical hypertrophic cardiomyopathy is a sign of left anterior descending artery stenosis: a case series
por: Arima, Naoki, et al.
Publicado: (2023)

Giant Left Atrial Myxoma in a Nonagenarian
por: Matsumura, Yoshihisa, et al.
Publicado: (2013)

Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort　― Results From the Kochi RYOMA Study ―
por: Kubo, Toru, et al.
Publicado: (2020)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Molecular Tweezers Targeting Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2014)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

Screening for hereditary transthyretin amyloidosis in Bulgaria
por: Nakov, Radislav, et al.
Publicado: (2021)

A Late Diagnosis of Transthyretin Amyloidosis
por: Pfirman, Kristopher S, et al.
Publicado: (2022)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
por: Bezerra, Filipa, et al.
Publicado: (2020)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report
por: Nakashima, Yasuteru, et al.
Publicado: (2015)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ov87bo9af4g5hgds006naf7mpq